Compare Moderna, Inc. (MRNA) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs ArcelorMittal SA — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while ArcelorMittal SA trades at $66.25 (market cap $50.01B). The key difference: ArcelorMittal SA is far larger — about 2.1× Moderna, Inc.'s market cap, and ArcelorMittal SA pays a 0.91% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | MT | |
|---|---|---|
Market Cap | $23.60B | $50.01B |
Sector | Health | Basic Materials |
52-Week High | $81.80 | $71.65 |
52-Week Low | $22.36 | $30.39 |
Enterprise Value | $19.70B | $59.33B |
Dividend Yield | — | 0.91% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
